Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities

Imaging biomarkers are frequently proposed as endpoints for clinical trials targeting brain amyloidosis in Alzheimer's disease (AD); however, the specific impact of amyloid-β (Aβ) aggregation on biomarker abnormalities remains elusive in AD. Using the McGill-R-Thy1-APP transgenic rat as a model...

Descripción completa

Detalles Bibliográficos
Autores principales: Parent, Maxime J., Zimmer, Eduardo R., Shin, Monica, Kang, Min Su, Fonov, Vladimir S., Mathieu, Axel, Aliaga, Antonio, Kostikov, Alexey, Do Carmo, Sonia, Dea, Doris, Poirier, Judes, Soucy, Jean-Paul, Gauthier, Serge, Cuello, A. Claudio, Rosa-Neto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729194/
https://www.ncbi.nlm.nih.gov/pubmed/29097597
http://dx.doi.org/10.1523/JNEUROSCI.1346-17.2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729194/
https://www.ncbi.nlm.nih.gov/pubmed/29097597
http://dx.doi.org/10.1523/JNEUROSCI.1346-17.2017

Ejemplares similares